Cargando…
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer’s disease using an indwelling CSF catheter
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176668/ https://www.ncbi.nlm.nih.gov/pubmed/37173791 http://dx.doi.org/10.1186/s40035-023-00358-w |
| _version_ | 1785040475328086016 |
|---|---|
| author | LaBarbera, Kelsie M. Sheline, Yvette I. Izzo, Nicholas J. Yuede, Carla M. Waybright, Lora Yurko, Raymond Edwards, Hannah M. Gardiner, Woodrow D. Blennow, Kaj Zetterberg, Henrik Börjesson-Hanson, Anne Morgan, Roger Davis, Charles S. Guttendorf, Robert J. Schneider, Lon S. DeKosky, Steven LeVine, Harry Grundman, Michael Caggiano, Anthony O. Cirrito, John R. Catalano, Susan M. Hamby, Mary E. |
| author_facet | LaBarbera, Kelsie M. Sheline, Yvette I. Izzo, Nicholas J. Yuede, Carla M. Waybright, Lora Yurko, Raymond Edwards, Hannah M. Gardiner, Woodrow D. Blennow, Kaj Zetterberg, Henrik Börjesson-Hanson, Anne Morgan, Roger Davis, Charles S. Guttendorf, Robert J. Schneider, Lon S. DeKosky, Steven LeVine, Harry Grundman, Michael Caggiano, Anthony O. Cirrito, John R. Catalano, Susan M. Hamby, Mary E. |
| author_sort | LaBarbera, Kelsie M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10176668 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101766682023-05-13 A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer’s disease using an indwelling CSF catheter LaBarbera, Kelsie M. Sheline, Yvette I. Izzo, Nicholas J. Yuede, Carla M. Waybright, Lora Yurko, Raymond Edwards, Hannah M. Gardiner, Woodrow D. Blennow, Kaj Zetterberg, Henrik Börjesson-Hanson, Anne Morgan, Roger Davis, Charles S. Guttendorf, Robert J. Schneider, Lon S. DeKosky, Steven LeVine, Harry Grundman, Michael Caggiano, Anthony O. Cirrito, John R. Catalano, Susan M. Hamby, Mary E. Transl Neurodegener Letter BioMed Central 2023-05-12 /pmc/articles/PMC10176668/ /pubmed/37173791 http://dx.doi.org/10.1186/s40035-023-00358-w Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Letter LaBarbera, Kelsie M. Sheline, Yvette I. Izzo, Nicholas J. Yuede, Carla M. Waybright, Lora Yurko, Raymond Edwards, Hannah M. Gardiner, Woodrow D. Blennow, Kaj Zetterberg, Henrik Börjesson-Hanson, Anne Morgan, Roger Davis, Charles S. Guttendorf, Robert J. Schneider, Lon S. DeKosky, Steven LeVine, Harry Grundman, Michael Caggiano, Anthony O. Cirrito, John R. Catalano, Susan M. Hamby, Mary E. A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer’s disease using an indwelling CSF catheter |
| title | A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer’s disease using an indwelling CSF catheter |
| title_full | A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer’s disease using an indwelling CSF catheter |
| title_fullStr | A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer’s disease using an indwelling CSF catheter |
| title_full_unstemmed | A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer’s disease using an indwelling CSF catheter |
| title_short | A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer’s disease using an indwelling CSF catheter |
| title_sort | phase 1b randomized clinical trial of ct1812 to measure aβ oligomer displacement in alzheimer’s disease using an indwelling csf catheter |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176668/ https://www.ncbi.nlm.nih.gov/pubmed/37173791 http://dx.doi.org/10.1186/s40035-023-00358-w |
| work_keys_str_mv | AT labarberakelsiem aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT shelineyvettei aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT izzonicholasj aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT yuedecarlam aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT waybrightlora aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT yurkoraymond aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT edwardshannahm aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT gardinerwoodrowd aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT blennowkaj aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT zetterberghenrik aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT borjessonhansonanne aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT morganroger aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT davischarless aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT guttendorfrobertj aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT schneiderlons aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT dekoskysteven aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT levineharry aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT grundmanmichael aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT caggianoanthonyo aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT cirritojohnr aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT catalanosusanm aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT hambymarye aphase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT labarberakelsiem phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT shelineyvettei phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT izzonicholasj phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT yuedecarlam phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT waybrightlora phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT yurkoraymond phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT edwardshannahm phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT gardinerwoodrowd phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT blennowkaj phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT zetterberghenrik phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT borjessonhansonanne phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT morganroger phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT davischarless phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT guttendorfrobertj phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT schneiderlons phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT dekoskysteven phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT levineharry phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT grundmanmichael phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT caggianoanthonyo phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT cirritojohnr phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT catalanosusanm phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter AT hambymarye phase1brandomizedclinicaltrialofct1812tomeasureaboligomerdisplacementinalzheimersdiseaseusinganindwellingcsfcatheter |